Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years

Artigo Acesso aberto

Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years

2002; Oxford University Press; Volume: 41; Issue: 8 Linguagem: Inglês

10.1093/rheumatology/41.8.892

ISSN

1460-2172

Autores

Gianfranco Ferraccioli, Elisa Gremese, Paola Tomietto, G. Favret, Robert J. D’Amato, Emma Di Poi,

Tópico(s)

Autoimmune and Inflammatory Disorders Research

Resumo

Objective. To evaluate two monotherapies followed by step‐up combination therapy with two or three complementary drugs in active rheumatoid arthritis (RA) in comparison with sulphasalazine (SSZ) alone.

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years